Back
Corcept Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
CORT
Corcept Therapeutics, Inc.
Last Price:
$82.64
Seasonality Move:
6.8%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and CORT is experiencing slight selling pressure.
Corcept Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.76 | Sell |
| 20-day SMA: | 83.51 | Sell |
| 50-day SMA: | 78.66 | Buy |
| 200-day SMA: | 73.84 | Buy |
| 8-day EMA: | 83.3 | Sell |
| 20-day EMA: | 82.64 | Buy |
| 50-day EMA: | 79.25 | Buy |
| 200-day EMA: | 50.88 | Buy |
Corcept Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.2 | Buy |
| Relative Strength Index (14 RSI): | 51.51 | Buy |
| Chaikin Money Flow: | -116058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (79.24 - 85.6) | Buy |
| Bollinger Bands (100): | (71.28 - 83.12) | Buy |
Corcept Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics, Inc. Stock
Is Corcept Therapeutics, Inc. Stock a Buy?
-
Corcept Therapeutics, Inc. share price is 82.65 while CORT 8-day simple moving average is 82.76, which is a Sell signal.
-
The stock price of CORT is 82.65 while Corcept Therapeutics, Inc. 20-day SMA is 83.51, which makes it a Sell.
-
Corcept Therapeutics, Inc. 50-day simple moving average is 78.66 while CORT share price is 82.65, making it a Buy technically.
-
CORT stock price is 82.65 and Corcept Therapeutics, Inc. 200-day simple moving average is 73.84, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
53
Corcept Therapeutics, Inc. (CORT)
is a Buy
Is Corcept Therapeutics, Inc. a Buy or a Sell?
-
Corcept Therapeutics, Inc. stock is rated a BuyThe current Corcept Therapeutics, Inc. [CORT] share price is $82.65. The Score for CORT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics, Inc. Stock Info
Market Cap:
8.7B
Price in USD:
82.65
Share Volume:
342.9K
Corcept Therapeutics, Inc. 52-Week Range
52-Week High:
117.33
52-Week Low:
49.00
Buy
53
Corcept Therapeutics, Inc. (CORT)
is a Buy
Corcept Therapeutics, Inc. Share Price Forecast
-
What is the Corcept Therapeutics, Inc. stock price today?The Corcept Therapeutics, Inc. stock price is 82.65 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics, Inc. is not overvalued.
Is Corcept Therapeutics, Inc. Stock a Buy?
-
Corcept Therapeutics, Inc. share price is 82.65 while CORT 8-day exponential moving average is 83.30, which is a Sell signal.
-
The stock price of CORT is 82.65 while Corcept Therapeutics, Inc. 20-day EMA is 82.64, which makes it a Buy.
-
Corcept Therapeutics, Inc. 50-day exponential moving average is 79.25 while CORT share price is 82.65, making it a Buy technically.
-
CORT stock price is 82.65 and Corcept Therapeutics, Inc. 200-day simple moving average is 50.88, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics, Inc.
Is Corcept Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.44 per share, and an increase next year of $0.37 per share.
Technical Analysis of Corcept Therapeutics, Inc.
Should I short Corcept Therapeutics, Inc. stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is 1.2, suggesting Corcept Therapeutics, Inc. is a Buy
-
Corcept Therapeutics, Inc. Relative Strength Index (RSI) is 51.51, which suggest Corcept Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Corcept Therapeutics, Inc. is (79.24 - 85.6), which suggest Corcept Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Corcept Therapeutics, Inc. is (71.28 - 83.12), which suggest Corcept Therapeutics, Inc. is a Buy
* Corcept Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.